levetiracetam has been researched along with Blood-Coagulation-Disorders* in 2 studies
2 other study(ies) available for levetiracetam and Blood-Coagulation-Disorders
| Article | Year |
|---|---|
Severe cortical damage associated with COVID-19 case report.
Symptoms of COVID-19, as reported during the SARS-CoV-2 pandemic in 2019-2020, are primarily respiratory and gastrointestinal, with sparse reports on neurological manifestations. We describe the case of a 17-year old female with Cornelia de Lange syndrome and well controlled epilepsy, who sustained significant cortical injury during a COVID-19 associated multi-inflammatory syndrome. Topics: Acute Kidney Injury; Adolescent; Airway Extubation; Anticonvulsants; Blood Coagulation Disorders; Bone Marrow Failure Disorders; Brain Diseases; Brain Edema; C-Reactive Protein; COVID-19; De Lange Syndrome; Disease Progression; Electroencephalography; Epilepsy; Female; Ferritins; Humans; Influenza B virus; Influenza, Human; Levetiracetam; Magnetic Resonance Imaging; Midazolam; Necrosis; Phenobarbital; Pseudomonas Infections; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Seizures; Sepsis; Systemic Inflammatory Response Syndrome; Tachycardia, Ventricular | 2021 |
Monitoring of biochemical parameters and coagulation tests in children with epilepsy treated with levetiracetam monotherapy.
Topics: Adolescent; Anticonvulsants; Blood Coagulation Disorders; Child; Child, Preschool; Drug Monitoring; Epilepsy; Female; Humans; Hypokalemia; Hyponatremia; Infant; International Normalized Ratio; Levetiracetam; Magnesium; Male; Partial Thromboplastin Time; Potassium; Prospective Studies; Prothrombin Time; Serum Albumin; Serum Globulins; Sodium; Water-Electrolyte Imbalance | 2019 |